Chronic Chagas disease with advanced cardiac complications in Japan: Case report and literature review

Kazuo Imai, Takuya Maeda, Yusuke Sayama, Morichika Osa, Kei Mikita, Ichiro Kurane, Yasushi Miyahira, Akihiko Kawana, Sachio Miura

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Due to the unprecedented recent increases in global migration, Chagas disease has become a global health threat and its epidemiology has drastically changed. Here we describe the first case in Japan of benznidazole treatment for chronic Chagas disease characterized by advanced cardiac complications. A 55-year-old Japanese-Brazilian woman who had previously presented with chronic heart failure was diagnosed as having Chagas disease and treated with benznidazole to prevent aggravation of her cardiac complications. However, benznidazole administration was stopped on day 56 due to severe drug-induced peripheral neuritis. Sixteen months later, her serologic test for Trypanosoma cruzi is still positive and she is being followed regularly by cardiology. Despite an estimated prevalence of over 4000 cases in Japan, only a few cases of Chagas disease have been reported. A Medline search revealed only 7 cases identified between 1995 and 2014 in Japan: in 6 cases, complications of chronic Chagas disease were apparent at the time of presentation, and sudden death occurred in 2 of these cases due to cardiac complications. This clinical case and literature review re-emphasize the urgent need to establish a surveillance network and improve the diagnostic methods and treatment framework for Chagas disease in Japan.

Original languageEnglish
Pages (from-to)240-242
Number of pages3
JournalParasitology International
Volume64
Issue number5
DOIs
Publication statusPublished - 2015 Oct 1
Externally publishedYes

Fingerprint

Chagas Disease
Japan
Chronic Disease
Neuritis
Trypanosoma cruzi
Serologic Tests
Sudden Death
Cardiology
Epidemiology
Heart Failure
Therapeutics
Pharmaceutical Preparations
benzonidazole

Keywords

  • Benznidazole
  • Chronic Chagas cardiomyopathy
  • Migrant
  • Peripheral neuritis
  • Trypanosoma cruzi

ASJC Scopus subject areas

  • Parasitology
  • Infectious Diseases
  • Medicine(all)

Cite this

Chronic Chagas disease with advanced cardiac complications in Japan : Case report and literature review. / Imai, Kazuo; Maeda, Takuya; Sayama, Yusuke; Osa, Morichika; Mikita, Kei; Kurane, Ichiro; Miyahira, Yasushi; Kawana, Akihiko; Miura, Sachio.

In: Parasitology International, Vol. 64, No. 5, 01.10.2015, p. 240-242.

Research output: Contribution to journalArticle

Imai, K, Maeda, T, Sayama, Y, Osa, M, Mikita, K, Kurane, I, Miyahira, Y, Kawana, A & Miura, S 2015, 'Chronic Chagas disease with advanced cardiac complications in Japan: Case report and literature review', Parasitology International, vol. 64, no. 5, pp. 240-242. https://doi.org/10.1016/j.parint.2015.02.005
Imai, Kazuo ; Maeda, Takuya ; Sayama, Yusuke ; Osa, Morichika ; Mikita, Kei ; Kurane, Ichiro ; Miyahira, Yasushi ; Kawana, Akihiko ; Miura, Sachio. / Chronic Chagas disease with advanced cardiac complications in Japan : Case report and literature review. In: Parasitology International. 2015 ; Vol. 64, No. 5. pp. 240-242.
@article{b6ca7803418a4a6691cfcb6ff17fad11,
title = "Chronic Chagas disease with advanced cardiac complications in Japan: Case report and literature review",
abstract = "Due to the unprecedented recent increases in global migration, Chagas disease has become a global health threat and its epidemiology has drastically changed. Here we describe the first case in Japan of benznidazole treatment for chronic Chagas disease characterized by advanced cardiac complications. A 55-year-old Japanese-Brazilian woman who had previously presented with chronic heart failure was diagnosed as having Chagas disease and treated with benznidazole to prevent aggravation of her cardiac complications. However, benznidazole administration was stopped on day 56 due to severe drug-induced peripheral neuritis. Sixteen months later, her serologic test for Trypanosoma cruzi is still positive and she is being followed regularly by cardiology. Despite an estimated prevalence of over 4000 cases in Japan, only a few cases of Chagas disease have been reported. A Medline search revealed only 7 cases identified between 1995 and 2014 in Japan: in 6 cases, complications of chronic Chagas disease were apparent at the time of presentation, and sudden death occurred in 2 of these cases due to cardiac complications. This clinical case and literature review re-emphasize the urgent need to establish a surveillance network and improve the diagnostic methods and treatment framework for Chagas disease in Japan.",
keywords = "Benznidazole, Chronic Chagas cardiomyopathy, Migrant, Peripheral neuritis, Trypanosoma cruzi",
author = "Kazuo Imai and Takuya Maeda and Yusuke Sayama and Morichika Osa and Kei Mikita and Ichiro Kurane and Yasushi Miyahira and Akihiko Kawana and Sachio Miura",
year = "2015",
month = "10",
day = "1",
doi = "10.1016/j.parint.2015.02.005",
language = "English",
volume = "64",
pages = "240--242",
journal = "Parasitology International",
issn = "1383-5769",
publisher = "Elsevier Ireland Ltd",
number = "5",

}

TY - JOUR

T1 - Chronic Chagas disease with advanced cardiac complications in Japan

T2 - Case report and literature review

AU - Imai, Kazuo

AU - Maeda, Takuya

AU - Sayama, Yusuke

AU - Osa, Morichika

AU - Mikita, Kei

AU - Kurane, Ichiro

AU - Miyahira, Yasushi

AU - Kawana, Akihiko

AU - Miura, Sachio

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Due to the unprecedented recent increases in global migration, Chagas disease has become a global health threat and its epidemiology has drastically changed. Here we describe the first case in Japan of benznidazole treatment for chronic Chagas disease characterized by advanced cardiac complications. A 55-year-old Japanese-Brazilian woman who had previously presented with chronic heart failure was diagnosed as having Chagas disease and treated with benznidazole to prevent aggravation of her cardiac complications. However, benznidazole administration was stopped on day 56 due to severe drug-induced peripheral neuritis. Sixteen months later, her serologic test for Trypanosoma cruzi is still positive and she is being followed regularly by cardiology. Despite an estimated prevalence of over 4000 cases in Japan, only a few cases of Chagas disease have been reported. A Medline search revealed only 7 cases identified between 1995 and 2014 in Japan: in 6 cases, complications of chronic Chagas disease were apparent at the time of presentation, and sudden death occurred in 2 of these cases due to cardiac complications. This clinical case and literature review re-emphasize the urgent need to establish a surveillance network and improve the diagnostic methods and treatment framework for Chagas disease in Japan.

AB - Due to the unprecedented recent increases in global migration, Chagas disease has become a global health threat and its epidemiology has drastically changed. Here we describe the first case in Japan of benznidazole treatment for chronic Chagas disease characterized by advanced cardiac complications. A 55-year-old Japanese-Brazilian woman who had previously presented with chronic heart failure was diagnosed as having Chagas disease and treated with benznidazole to prevent aggravation of her cardiac complications. However, benznidazole administration was stopped on day 56 due to severe drug-induced peripheral neuritis. Sixteen months later, her serologic test for Trypanosoma cruzi is still positive and she is being followed regularly by cardiology. Despite an estimated prevalence of over 4000 cases in Japan, only a few cases of Chagas disease have been reported. A Medline search revealed only 7 cases identified between 1995 and 2014 in Japan: in 6 cases, complications of chronic Chagas disease were apparent at the time of presentation, and sudden death occurred in 2 of these cases due to cardiac complications. This clinical case and literature review re-emphasize the urgent need to establish a surveillance network and improve the diagnostic methods and treatment framework for Chagas disease in Japan.

KW - Benznidazole

KW - Chronic Chagas cardiomyopathy

KW - Migrant

KW - Peripheral neuritis

KW - Trypanosoma cruzi

UR - http://www.scopus.com/inward/record.url?scp=84924601241&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924601241&partnerID=8YFLogxK

U2 - 10.1016/j.parint.2015.02.005

DO - 10.1016/j.parint.2015.02.005

M3 - Article

C2 - 25744336

AN - SCOPUS:84924601241

VL - 64

SP - 240

EP - 242

JO - Parasitology International

JF - Parasitology International

SN - 1383-5769

IS - 5

ER -